W. Choi

Learn More
Cetuximab, a chimeric monoclonal antibody developed for targeting the Epidermal Growth Factor Receptor (EGFR), has been intensively used to treat cancer patients with metastatic colorectal cancer and head and neck cancer. Intact immunoglobulin G (IgG) antibody like cetuximab, however, has some limitations such as high production cost and low penetration(More)
A case of meningioangiomatosis without neurofibromatosis, a rare disorder, is described. These patients are usually young (mean age, 27 years) and frequently present with seizures that resolve following partial or total resection of the lesion. The lesions are firm and well demarcated grossly with areas of calcification. Only single lesions have been(More)
The feasibility of medium-high fraction SiGe based FinFET pMOS devices for a sub-10nm CMOS logic technology from a performance (I<sub>EFF</sub> @ fixed I<sub>OFF</sub>) standpoint is evaluated, considering three key device aspects - stress, band-to-band-tunneling (BTBT), and interface charge density (DIT). The analysis reveals that while for high Ge(More)
Sinus histiocytosis with massive lymphadenopathy is a non-neoplastic self-limiting disease of the bone marrow stem cell origin. It is characterized by painless, bilateral cervical lymphadenopathy accompanied by fever, leukocytosis, elevated erythrocyte sedimentation rate and hypergammaglobulinemia. Extranodal involvement including bone is rare. The patient(More)
Subependymoma is a rare, slow-growing, benign noninvasive tumor of the central nervous system that may be located in the fourth ventricle, the septum pellucidum, the third and the lateral ventricles, the aqueduct, and the proximal spinal cord. Symptoms, if any, usually result either from direct compression of the brain stem or from acute hydrocephalus due(More)
  • 1